COVID concerns highlight the importance of adequate fecal immunochemical test sample collection
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Recent surveys suggest that many people, concerned about contracting coronavirus disease 2019 (COVID‐19) through public exposure, have been forgoing cancer screening tests. (The American Society of Clinical Oncology, for example, found that approximately two‐thirds of those who were scheduled to receive cancer screenings during the pandemic reported missing or delaying them.) Although fecal occult blood tests, including FIT, that can be performed at home offer a good solution for most individuals who are concerned about getting a screening colonoscopy at this time, some previous studies have raised concerns that suboptimal stool collection by patients might lead to false‐negative results.
CA: A Cancer Journal for Clinicians , article en libre accès, 2021